UroGen Pharma Ltd. (URGN) EBITDA Margin (2018 - 2026)
UroGen Pharma (URGN) posted EBITDA Margin of 0.29% for Q2 2026, up 171.04 percentage points from -170.75% a year earlier and up 39.86 percentage points from the prior quarter.
Powered by 
Analysis
UroGen Pharma Ltd. (URGN) EBITDA Margin (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at UroGen Pharma was -35.12%, up 95.65 percentage points year-over-year; for FY2025, it was -113.45%, down 6.75 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +957.17 percentage points (FY2020 to FY2025).
- In prior years, UroGen Pharma's EBITDA Margin was -106.70% in FY2024 (-28.43 pp), -78.26% in FY2023 (+43.12 pp), -121.38% in FY2022 (+69.00 pp) and -190.38% in FY2021 (+880.25 pp).
- The Q2 2026 figure stands as the highest quarterly EBITDA Margin in data going back to Q1 2018.
- On a year-over-year basis, EBITDA Margin has increased in each of the last three quarters, with an average year-over-year change of +23.80 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q3 2021, with a gain of 633.86 percentage points; the weakest was Q2 2025, with a drop of 52.94 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -39.57% (Q1 2026), -50.32% (Q4 2025) and -99.29% (Q3 2025).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.29% |
| Mar 31, 2026 | -39.57% |
| Dec 31, 2025 | -50.32% |
| Sep 30, 2025 | -99.29% |
| Jun 30, 2025 | -170.75% |
| Mar 31, 2025 | -181.76% |
| Dec 31, 2024 | -112.47% |
| Sep 30, 2024 | -69.22% |
| Jun 30, 2024 | -117.81% |
| Mar 31, 2024 | -136.40% |
| Dec 31, 2023 | -61.28% |
| Sep 30, 2023 | -63.78% |
| Jun 30, 2023 | -71.82% |
| Mar 31, 2023 | -126.97% |
| Dec 31, 2022 | -110.87% |
| Sep 30, 2022 | -111.12% |
| Jun 30, 2022 | -111.51% |
| Mar 31, 2022 | -160.29% |
| Dec 31, 2021 | -121.81% |
| Sep 30, 2021 | -204.74% |
API Access
UroGen Pharma Ltd. EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();